US Dollar vs Yen

登録して無料でリアルタイムの株価、インタラクティブチャート、ライブオプションフローなどを入手してください。

登録

PCVX

Vaxcyte (PCVX)

Vaxcyte Inc

から:

Regulatory News

Text Search:

次の項目別のソート:

Non-Regulatory News

Showing the most relevant articles for your search:NASDAQ:PCVX

1 2 3 4 5 6 7 8 9 10 次へ >>

日付	受信時刻	ニュースソース	見出し	コード	企業名
2024/06/11	05 : 19	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:PCVX	Vaxcyte Inc
2024/06/11	05 : 13	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:PCVX	Vaxcyte Inc
2024/06/11	05 : 12	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:PCVX	Vaxcyte Inc
2024/06/11	05 : 11	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:PCVX	Vaxcyte Inc
2024/06/11	05 : 07	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:PCVX	Vaxcyte Inc
2024/06/06	05 : 58	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:PCVX	Vaxcyte Inc
2024/06/06	05 : 57	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:PCVX	Vaxcyte Inc
2024/06/04	05 : 02	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:PCVX	Vaxcyte Inc
2024/06/04	05 : 00	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:PCVX	Vaxcyte Inc
2024/05/25	06 : 05	Edgar (US Regulatory)	Form S-3ASR - Automatic shelf registration statement of securities of well-known seasoned issuers	NASDAQ:PCVX	Vaxcyte Inc
2024/05/09	05 : 10	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:PCVX	Vaxcyte Inc
2024/05/09	05 : 08	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:PCVX	Vaxcyte Inc
2024/05/09	05 : 05	GlobeNewswire Inc.	Vaxcyte Reports First Quarter 2024 Financial Results and Provides Business Update	NASDAQ:PCVX	Vaxcyte Inc
2024/04/03	05 : 05	GlobeNewswire Inc.	Vaxcyte to Present at the 23rd Annual Needham Virtual Healthcare Conference	NASDAQ:PCVX	Vaxcyte Inc
2024/03/05	11 : 23	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:PCVX	Vaxcyte Inc
2024/03/05	11 : 22	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:PCVX	Vaxcyte Inc
2024/03/05	11 : 21	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:PCVX	Vaxcyte Inc
2024/03/04	22 : 30	GlobeNewswire Inc.	Vaxcyte Completes Enrollment of Phase 2 Study Evaluating VAX-24 for the Prevention of Invasive Pneumococcal Disease (IPD) in Infants	NASDAQ:PCVX	Vaxcyte Inc
2024/03/02	06 : 02	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:PCVX	Vaxcyte Inc
2024/03/02	06 : 00	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:PCVX	Vaxcyte Inc
2024/02/28	06 : 58	Edgar (US Regulatory)	Form S-8 - Securities to be offered to employees in employee benefit plans	NASDAQ:PCVX	Vaxcyte Inc
2024/02/28	06 : 02	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:PCVX	Vaxcyte Inc
2024/02/28	06 : 01	GlobeNewswire Inc.	Vaxcyte Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update	NASDAQ:PCVX	Vaxcyte Inc
2024/02/21	06 : 22	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:PCVX	Vaxcyte Inc
2024/02/16	06 : 05	GlobeNewswire Inc.	Vaxcyte to Report Fourth Quarter and Full Year 2023 Financial Results on February 27, 2024	NASDAQ:PCVX	Vaxcyte Inc
2024/02/06	07 : 39	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:PCVX	Vaxcyte Inc
2024/02/06	07 : 37	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:PCVX	Vaxcyte Inc
2024/02/03	08 : 39	GlobeNewswire Inc.	Vaxcyte Announces Closing of $862.5 Million Public Offering Including Full Exercise of Underwriters’ Option to Purchase Additional Shares	NASDAQ:PCVX	Vaxcyte Inc
2024/02/02	06 : 07	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:PCVX	Vaxcyte Inc
2024/02/02	06 : 06	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:PCVX	Vaxcyte Inc

Showing the most relevant articles for your search:NASDAQ:PCVX

1 2 3 4 5 6 7 8 9 10 次へ >>

Bank of America

Health Care Select Sector

US Dollar vs Yen

American Express

BNP Paribas (QX)

Delayed Upgrade Clock

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約